Med. praxi. 2010;7(2):58-63

Complex treatment of a diabetic patient in a GP‘s surgery

MUDr.Igor Karen1, MUDr.Zdeněk Hamouz2
1 praktický lékař pro dospělé, Benátky nad Jizerou
2 praktický lékař pro dospělé, Chomutov

In recent years, diabetes mellitus (DM) has been an increasing public health problem in both developed and developing countries. More

often than not, it feels like a cliché to me. The Czech Republic is way behind in the care of the diabetic patient. Beginning this year, GPs

(general practitioners) can treat uncomplicated type 2 diabetic patients in their practice. Up to now, they have not been paid for this work

and, what is more, it has not been considered by health insurance companies in terms of regulations. Paradoxically enough, sometimes GPs

were even penalized by higher costs for laboratories and drugs. In an overall effect, it was rather demotivating for general practitioners.

Since 1st January 2010, general practitioners have finally been provided with an opportunity to treat an uncomplicated diabetic patient.

In the European context, when the Euro Diabetes Consumer Index (EDCI) concerning the quality of diabetes care was assessed, the Czech

Republic ranked 23rd among 28 European countries. Is it really only a matter of glycaemia ? In addition to glycaemia, is it not necessary to

manage hypertension and dyslipidaemia ? How much can the subsequent risks in patients be reduced by a consistent treatment of these

risks ? How expensive will the reversal of damage be if they are not treated adequately ? Is treatment of hypertension not as important

as hypoglycaemic treatment ? The number of diabetics in the population is increasing but the number of diabetologist services is not.

Therefore, following a series of negotiations with the ministry of health, better availability and improved quality of care, particularly of

newly detected diabetics in GP surgeries have been advocated.

Keywords: diabetes mellitus, definition, diagnosis, complications, prevention

Published: April 22, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Karen I, Hamouz Z. Complex treatment of a diabetic patient in a GP‘s surgery. Med. praxi. 2010;7(2):58-63.
Download citation

References

  1. Holman RR, Thorne KI, Farmer AJ, Davies MJ, Keenan JF, Paul S, Levy JC, for the 4-T Study Group. Addition of Biphasic, Prandial, or Basal Insulin to Oral Therapy in Type 2 Diabetes. NEJM Volume 357: 1716-1730. Go to original source... Go to PubMed...
  2. Holman RR, Farmer AJ, Davies MJ, Levy JC, Darbyshire JL, Keenan JF, Paul SK, for the 4-T Study Group. Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes. NEJM Volume 361: 1736-1747. Go to original source... Go to PubMed...
  3. Doporučené postupy SVL ČLS JEP: Karen I, Kvapil M. DM 2008.
  4. Standardy péče o diabetes mellitus 2. typu. Výbor ČDS ČLS JEP. DMEV, 2007; 10: 191-198.
  5. Standardy České diabetologické společnosti: www.diab.cz.
  6. Doporučené postupy SVL ČLS JEP: Karen I, Widimský J. Arteriální hypertenze, 2008.
  7. Doporučené postupy SVL ČLS JEP: Herber O, Býma S, Karen I. Dyslipidémie, Prevence KVO 2004.
  8. Doporučené postupy SVL ČLS JEP: Karen I, Souček M. Metabolický syndrom - diagnostika a léčba 2007.
  9. www.svl.cz
  10. Rybka J, a spol. Ambulantní péče o diabetika, 2000.
  11. European Diabetes Policy Group: Guidelines for Diabetes Care. A Desktop Guide to Type 2 Diabetes Mellitus. IDF European region. Germany: Walter Wirtz Druck Verlag, 1999. Go to original source...
  12. Svačina Š. Prevence diabetu a jeho komplikací. Praha: Triton, 2008: 152 s.
  13. Škrha J. Farmakoterapie diabetes mellitus. In: Marek J, a kol. Farmakoterapie nemocí vnitřních. 3. vyd. Praha: Grada, 2005: 413-425. (4. vydání, 2009 v tisku).
  14. Svačina Š, a kol. Klinická dietologie. Praha: Grada Publishing, 2008: 381 s.
  15. Kvapil M, Adamčíková A, Anděl M, Olšovský A, Pelikánová T, Račická E, Rušavý Z. Diabetologie, metabolismus, endokrinologie, výživa... Konsenzus k léčbě inzulinovými analogy.
  16. Perušičová J. Perorální antidiabetika. In: Perušičová J, a kol. Trendy soudobé diabetologie, sv. 1. Praha: Galén, 1998.
  17. Perušičová J. Desatera léčby perorálními antidiabetiky. Praha: Triton, 2004.
  18. Bartoš V, Pelikánová T, a kol. Praktická diabetologie. 3. vyd. Praha: Maxdorf Jesenius, s.r.o., 2003.
  19. Olšovský J, Žáčková V. Diabetologie. In: Zicha J, a kol. Rukověť základů praktické interny. MU v Brně, 2001: 188-196.
  20. Keen H. Therapeutic Objectives and Their Practical Achievement in Type 2 Diabetes. In: Journal of Diabetes and Its Complications 2000; 14: 180-184. Go to original source... Go to PubMed...
  21. Morris AD. The reality of Type 2 Diabetes Treatment Today. In: International Journal of Clinical Practice 2001; suppl 121: 32-35. Go to PubMed...
  22. Pickup JC, Williams G. Textbook of Diabetes, Management of Non-inzulin-dependent Diabetes Mellitus, Second Edition, Blackwell Science Ltd., 1998; S 8: chapter 37, 38.
  23. Sinagra D. Effects of Inzulin-oral Hypoglycemic Agents Combined Therapy in Outpatients with Type 2 Diabetes. In: European Review for Medical and Pharmacological Sciences, 1998; 2(5-6): 175-179. Go to PubMed...
  24. Alberti KG. Treating Type 2 Diabetes - Today's Targets, Tomorrow's Goals. Abstract Book 36th Congress EASD, Jerusalem. September 2000: 6-7.
  25. Consensus Statement for the Management of Patients with Type 2 Diabetes Mellitus in the Central, Eastern and Southern European region, November 1999 - January 2000, Budapest.
  26. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B. Medical Management of Hyperglycemia in Type 2 Diabetes: a Consensus Algorithm for the Initiation and Adjustment of Therapy. In: Diab Care, 2008; 31.




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.